USE OF INSULIN GLARGINE TO REDUCE OR PREVENT CARDIOVASCULAR MORBIDITY AND MORTALITY IN PRE-DIABETES PATIENTS

• 收藏
• 分享

专利权人:

AVENTIS PHARMACEUTICALS INC.

发明人:

RALF ROSSKAMP,HERTZEL GERSTEIN

申请号：

PT13155801

公开号：

PT2596800T

申请日:

2004.01.14

申请国别(地区):

PT

年份:

2016

代理人:

摘要：

This invention relates to a method of reducing cardiovascular morbidity and mortality in a prediabetic or Type 2 Diabetes patient population. The method comprises administering an effective dosage of a long acting insulin, preferably insulin glargine, to a prediabetic or Type 2 Diabetes patient.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/